口咽癌放疗与手术后长期患者报告结局:基于人群队列研究
本研究利用德克萨斯癌症登记处识别2006年1月1日至2016年12月31日接受根治性放疗或手术的口咽鳞状细胞癌生存者,于2020年10月和2021年4月进行调查。共400人应答(应答率25%),最终分析纳入396例。多变量调整后,手术与放疗在MDASI-HN、NDII和EAR量表上均无显著差异;教育程度较低、家庭收入较低和管饲使用与三项评分显著更差相关,同步化疗与更差的MDASI-HN和EAR评分相关。
要点
- 多变量调整后手术与放疗的长期患者报告结局无显著差异
- 较低教育程度、较低家庭收入及管饲使用与三项评分显著更差相关
- 同步化疗与更差的MDASI-HN和EAR评分相关
核心结论
- 基于人群的队列研究发现口咽鳞状细胞癌的长期患者报告结局与初始放疗或手术无关联。
- 较低社会经济地位、管饲使用和同步化疗与更差的长期患者报告结局相关。
- 作者认为进一步工作应关注这些长期治疗毒性的机制、预防和康复。
- 作者认为同步化疗的长期结局应被验证,并可能为治疗决策提供信息。
研究设计与样本
- 横断面研究,使用德克萨斯癌症登记处识别2006年1月1日至2016年12月31日间接受根治性放疗或手术的口咽鳞状细胞癌生存者。
- 患者于2020年10月和2021年4月接受调查。
- 问卷寄送至1600名生存者,400人应答(应答率25%),其中183人(46.2%)距初次诊断8至15年。
- 最终分析纳入396例患者:年龄≤57岁190例(48.0%),年龄>57岁206例(52.0%);女性72例(18.2%),男性324例(81.8%)。
主要发现
- 多变量调整后,手术与放疗在MDASI-HN评分上无显著差异(β,-0.1;95%CI,-0.7至0.6)。
- 多变量调整后,手术与放疗在NDII评分上无显著差异(β,-1.7;95%CI,-6.7至3.4)。
- 多变量调整后,手术与放疗在EAR评分上无显著差异(β,-0.9;95%CI,-7.7至5.8)。
- 较低教育程度、较低家庭收入及管饲使用与显著更差的MDASI-HN、NDII和EAR评分相关。
- 同步化疗联合放疗与更差的MDASI-HN和EAR评分相关。
关键数值与推荐
- MDASI-HN:手术 vs 放疗 β,-0.1;95%CI,-0.7至0.6。
- NDII:手术 vs 放疗 β,-1.7;95%CI,-6.7至3.4。
- EAR:手术 vs 放疗 β,-0.9;95%CI,-7.7至5.8。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Oncologic outcomes are similar for patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with primary surgery or radiotherapy. However, comparative differences in long-term patient-reported outcomes (PROs) between modalities are less well established. OBJECTIVE: To determine the association between primary surgery or radiotherapy and long-term PROs. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used the Texas Cancer Registry to identify survivors of OPSCC treated definitively with primary radiotherapy or surgery between January 1, 2006, and December 31, 2016. Patients were surveyed in October 2020 and April 2021. EXPOSURES: Primary radiotherapy and surgery for OPSCC. MAIN OUTCOMES AND MEASURES: Patients completed a questionnaire that included demographic and treatment information, the MD Anderson Symptom Inventory-Head and Neck (MDASI-HN) module, the Neck Dissection Impairment Index (NDII), and the Effectiveness of Auditory Rehabilitation (EAR) scale. Multivariable linear regression models were performed to evaluate the association of treatment (surgery vs radiotherapy) with PROs while controlling for additional variables. RESULTS: Questionnaires were mailed to 1600 survivors of OPSCC identified from the Texas Cancer Registry, with 400 responding (25% response rate), of whom 183 (46.2%) were 8 to 15 years from their initial diagnosis. The final analysis included 396 patients (aged ≤57 years, 190 [48.0%]; aged >57 years, 206 [52.0%]; female, 72 [18.2%]; male, 324 [81.8%]). After multivariable adjustment, no significant differences were found between surgery and radiotherapy outcomes as measured by the MDASI-HN (β, -0.1; 95% CI, -0.7 to 0.6), NDII (β, -1.7; 95% CI, -6.7 to 3.4), and EAR (β, -0.9; 95% CI -7.7 to 5.8). In contrast, less education, lower household income, and feeding tube use were associated with significantly worse MDASI-HN, NDII, and EAR scores, while concurrent chemotherapy with radiotherapy was associated with worse MDASI-HN and EAR scores. CONCLUSIONS AND RELEVANCE: This population-based cohort study found no associations between long-term PROs and primary radiotherapy or surgery for OPSCC. Lower socioeconomic status, feeding tube use, and concurrent chemotherapy were associated with worse long-term PROs. Further efforts should focus on the mechanism, prevention, and rehabilitation of these long-term treatment toxicities. The long-term outcomes of concurrent chemotherapy should be validated and may inform treatment decision making.
引用
- Dohopolski MJ, Diao K, Hutcheson KA, et al. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37382943. doi:10.1001/jamaoto.2023.1323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。